Kidney Disease Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Kidney Disease Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Tablets
Capsule
Other
Segment by Application
Chronic Glomerulonephritis
Nephrotic Syndrome
Chronic Renal Failure
Kidney Stones
Renal Cyst (polycystic Kidney)
Diabetic Nephropathy
Hypertensive Nephropathy
Purpura Nephritis
Lupus Nephritis
By Company
GlaxoSmithKline
Sanofi
Roche
Pfizer
AstraZeneca
Keryx Biopharmaceuticals
Kissei Pharmaceutical
AbbVie
Amgen
Teva Pharmaceutical Industries
Tianjin Tongrentang Group
Jiangxi Jimin Kexin Jinshuibao Pharmaceutical
Datong Liqun Pharmaceutical
Hebei Ruisen Pharmaceutical
Changxing Pharmaceutical
zhejiang Shengbokang Pharmaceutical
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
